Baylor St. Luke’s Medical Center has been recognized as a GammaTile Center of Excellence by GT Medical Technologies, a company that develops medical devices for brain tumor treatment.
This designation is given to healthcare providers who demonstrate expertise in the GammaTile procedure, meet specific clinical requirements, and maintain ongoing education and case volume standards. Physicians at Baylor St. Luke’s have now received this recognition for their work with the technology.
"Achieving designation as a GammaTile Center of Excellence highlights our team’s dedication to bringing innovative treatment options to patients with operable brain tumors,” said Dr. Ganesh Rao, Physician Lead for the Neuroscience Service Line at Baylor St. Luke’s Medical Center and Professor and Marc J. Shapiro Chair of Neurosurgery at Baylor College of Medicine. “With GammaTile, we can deliver targeted radiation precisely where it is needed at the time of surgery, minimizing exposure to healthy tissue. At Baylor St. Luke’s Medical Center, we believe that GammaTile is an important advancement in brain tumor care that strengthens our ability to provide the best treatment available to our patients.”
GammaTile therapy involves placing a form of radiation treatment directly into the area where a tumor was removed during surgery. This allows for immediate and localized delivery of radiation when cancer cells are most vulnerable after surgery. The approach differs from traditional methods that often delay radiation until after surgical wounds heal, potentially reducing the risk of tumor regrowth by targeting any remaining cancer cells without exposing surrounding healthy tissue.
